JavaScript is disabled for your browser. Some features of this site may not work without it.
  • About K
  • Academics
  • Admission
  • Alumni Relations
  • Giving to K
  • News & Events
  • Student Life
  • HORNET HIVE
  • ATHLETICS
  • SITEMAP
  • WEBMAIL
    • Login
    View Item 
    •   CACHE Homepage
    • Academic Departments, Programs, and SIPs
    • Biology
    • Biology Senior Individualized Projects
    • View Item
    •   CACHE Homepage
    • Academic Departments, Programs, and SIPs
    • Biology
    • Biology Senior Individualized Projects
    • View Item

    Altered Eicosanoid Metabolism Associates with the Salutary Changes of Salt Restriction In Chronic Kidney Disease

    Thumbnail
    View/Open
    Searchable PDF/Kalamazoo College Only (1.013Mb)
    Date
    2019
    Author
    Petroff, Julia N.
    Metadata
    Show full item record
    Abstract
    Chronic Kidney Disease (CKD) is a global health crisis affecting 11 to 13% of people worldwide. It often coincides with the development of hypertension, making hypertension a critical predictor of CKD progression. Hypertension is generally linked to increased salt intake and can be treated with antihypertensive drugs and/or a salt restricted diet (SRD). However, antihypertensive medications don’t work in patients with salt sensitivity, which means their only treatment option is a salt restricted diet. Diagnosis of salt sensitivity takes time, since the current method of identification is inconvenient and tedious. Generally, salt sensitivity is determined when physicians recognize the ineffectiveness of antihypertensive drugs. As more hypertensive patients have become salt sensitive, the necessity of a simpler, more effective identification method has increased. Current studies are focusing on finding potential biomarkers of salt sensitivity, but little is done in patients with CKD. Our study aimed to identify potential eicosanoid metabolites as salt sensitivity biomarkers in CKD patients by studying their concentration changes in response to SRD. Serum and urine samples were collected from 34 patients enrolled in the LoSalt trial. This is a randomized crossover trial of CKD stage 3-4 patients who underwent SRD. Targeted metabolomic analysis of eicosanoid metabolites in pre and post SRD serum and urine were performed with liquid chromatography-mass spectrometry. While we did not find significant evidence of SRD’s effects on eicosanoid concentration, we did see trends that indicate a relationship. Arachidonic acid and resolvin D1 demonstrated a trend of increased concentration, while 14(15)-epoxyeicosatrienoic acid and 5-iso-Prostaglandin F2α-VI demonstrated a trend of decreased concentration. In order to identify these four eicosanoids as salt sensitivity markers, further studies are needed to determine if SRD has a significant effect on them as well as the eicosanoids’ connection to changes in blood pressure.
    URI
    http://hdl.handle.net/10920/36753
    Collections
    • Biology Senior Individualized Projects [1550]

    Browse

    All of DSpaceCommunities & CollectionsBy Issue DateAuthorsTitlesSubjectsThis CollectionBy Issue DateAuthorsTitlesSubjects

    My Account

    Login

    DSpace software copyright © 2002-2021  DuraSpace
    DSpace Express is a service operated by 
    Atmire NV
    Logo

    Kalamazoo College
    1200 Academy Street
    Kalamazoo Michigan 49006-3295
    USA
    Info 269-337-7000
    Admission 1-800-253-3602

    About K
    Academics
    Admission
    Alumni Relations
    Giving to K
    News & Events
    Student Life
    Sitemap
    Map & Directions
    Contacts
    Directories
    Nondiscrimination Policy
    Consumer Information
    Official disclaimer
    Search this site


    Academic Calendars
    Apply
    Bookstore
    Crisis Response
    Employment
    Library
    Registrar
    DSpace Express is a service operated by 
    Atmire NV